Type I epithelial cells are the main target of whole-body hypoxic preconditioning in the lung

American Journal of Respiratory Cell and Molecular Biology

Volumn 40, Issue 3, 2009, Pages 332-339

  Zhang, Shelley X L ^a   Miller, James J ^b   Stolz, Donna Beer ^c   Serpero, Laura D ^a   Zhao, Wei ^b   Gozal, David ^a   Wang, Yang ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alveolar fluid clearance; Cytoprotection; High altitude diseases; Pulmonary edema; Pulmonary hypertension

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CAVEOLIN 2; CREATINE KINASE; HEAT SHOCK PROTEIN; LACTATE DEHYDROGENASE; MANGANESE SUPEROXIDE DISMUTASE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; BIOLOGICAL MARKER; VON WILLEBRAND ANTIGEN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CIRCULATION; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ELECTRON MICROSCOPY; ENZYME RELEASE; EPITHELIUM CELL; HYPOXIA; LUNG ALVEOLUS CELL TYPE 1; LUNG ALVEOLUS CELL TYPE 2; LUNG EDEMA; LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION; VASCULAR ENDOTHELIUM; ANIMAL; ANOXIA; C57BL MOUSE; CYTOLOGY; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; ANOXIA; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOPROTECTION; EPITHELIAL CELLS; LUNG; LUNG INJURY; MALE; MICE; MICE, INBRED C57BL; VON WILLEBRAND FACTOR;

MUS;

EID: 61549104463     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0003OC     Document Type: Article

References (52)

1. Bartsch P, Mairbaurl H, Maggiorini M, Swenson ER. Physiological aspects of high-altitude pulmonary edema. J Appl Physiol 2005;98: 1101-1110.
2. Sartori C, Allemann Y, Scherrer U. Pathogenesis of pulmonary edema: learning from high-altitude pulmonary edema. Respir Physiol Neurobiol 2007;159:338-349.
3. Staub NC. Pulmonary edema. Physiol Rev 1974;54:678-811.
4. Weir EK, Reeves JT. Pulmonary edema. Armonk, NY: Futura Pub. Co.; 1998.
5. Gallagher SA, Hackett PH. High-altitude illness. Emerg Med Clin North Am 2004;22:329-355, viii.
6. Dehnert C, Risse F, Ley S, Kuder TA, Buhmann R, Puderbach M, Menold E, Mereles D, Kauczor HU, Bartsch P, et al. Magnetic resonance imaging of uneven pulmonary perfusion in hypoxia in humans. Am J Respir Crit Care Med 2006;174:1132-1138.
7. Hlastala MP, Lamm WJ, Karp A, Polissar NL, Starr IR, Glenny RW. Spatial distribution of hypoxic pulmonary vasoconstriction in the supine pig. J Appl Physiol 2004;96:1589-1599.
8. Hopkins SR, Garg J, Bolar DS, Balouch J, Levin DL. Pulmonary blood flow heterogeneity during hypoxia and high-altitude pulmonary edema. Am J Respir Crit Care Med 2005;171:83-87.
9. Tsukimoto K, Mathieu-Costello O, Prediletto R, Elliott AR, West JB. Ultrastructural appearances of pulmonary capillaries at high transmural pressures. J Appl Physiol 1991;71:573-582.
10. West JB, Colice GL, Lee YJ, Namba Y, Kurdak SS, Fu Z, Ou LC, Mathieu-Costello O. Pathogenesis of high-altitude pulmonary oedema: direct evidence of stress failure of pulmonary capillaries. Eur Respir J 1995;8:523-529.
11. Dada LA, Chandel NS, Ridge KM, Pedemonte C, Bertorello AM, Sznajder JI. Hypoxia-induced endocytosis of Na,K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta. J Clin Invest 2003;111:1057-1064.
12. Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990;142:1250-1257.
13. Planes C, Escoubet B, Blot-Chabaud M, Friedlander G, Farman N, Clerici C. Hypoxia downregulates expression and activity of epithelial sodium channels in rat alveolar epithelial cells. Am J Respir Cell Mol Biol 1997;17:508-518.
14. Bachofen H, Schurch S, Weibel ER. Experimental hydrostatic pulmonary edema in rabbit lungs: barrier lesions. Am Rev Respir Dis 1993; 147:997-1004.
15. Costello ML, Mathieu-Costello O, West JB. Stress failure of alveolar epithelial cells studied by scanning electron microscopy. Am Rev Respir Dis 1992;145:1446-1455.
16. Sobin SS, Chen PC. Ultrastructural changes in the pulmonary arterioles in acute hypoxic pulmonary hypertension in the rat. High Alt Med Biol 2000;1:311-322.
17. Nagamine J, Hill LL, Pearl RG. Combined therapy with zaprinast and inhaled nitric oxide abolishes hypoxic pulmonary hypertension. Crit Care Med 2000;28:2420-2424.
18. Scherrer U, Vollenweider L, Delabays A, Savcic M, Eichenberger U, Kleger GR, Fikrle A, Ballmer PE, Nicod P, Bartsch P. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med 1996;334:624-629.
19. Sartori C, Allemann Y, Duplain H, Lepori M, Egli M, Lipp E, Hutter D, Turini P, Hugli O, Cook S, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002;346:1631-1636.
20. Bartsch P, Mairbaurl H. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002;347:1282-1285.
21. Litvan J, Briva A, Wilson MS, Budinger GR, Sznajder JI, Ridge KM. β-adrenergic receptor stimulation and adenoviral overexpression of superoxide dismutase prevent the hypoxia-mediated decrease in Na,K-ATPase and alveolar fluid reabsorption. J Biol Chem 2006; 281:19892-19898.
22. Zhang SX, Miller JJ, Gozal D, Wang Y. Whole-body hypoxic preconditioning protects mice against acute hypoxia by improving lung function. J Appl Physiol 2004;96:392-397.
23. Zhang SX, Searcy TR, Wu Y, Gozal D, Wang Y. Alternative promoter usage and alternative splicing contribute to mRNA heterogeneity of mouse monocarboxylate transporter 2. Physiol Genomics 2007;32:95-104.
24. Krasteva G, Pfeil U, Drab M, Kummer W, Konig P. Caveolin-1 and-2 in airway epithelium: expression and in situ association as detected by FRET-CLSM. Respir Res 2006;7:108.
25. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, Mednick G, Matthay ZA, Matthay MA. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006;173:1008-1015.
26. Doyle IR, Bersten AD, Nicholas TE. Surfactant proteins-A and-B are elevated in plasma of patients with acute respiratory failure. Am J Respir Crit Care Med 1997;156:1217-1229.
27. Rubin DB, Wiener-Kronish JP, Murray JF, Green DR, Turner J, Luce JM, Montgomery AB, Marks JD, Matthay MA. Elevated von willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990;86:474-480.
28. Wang Y, Guo Y, Zhang SX, Wu WJ, Wang J, Bao W, Bolli R. Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte. J Mol Cell Cardiol 2002;34:5-15.
29. Wang Y, Kodani E, Wang J, Zhang SX, Takano H, Tang XL, Bolli R. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal no synthase in concert with cyclooxygenase-2. Circ Res 2004;95:84-91.
30. Hoschele S, Mairbaurl H. Alveolar flooding at high altitude: failure of reabsorption? News Physiol Sci 2003;18:55-59.
31. Jain M, Sznajder JI. Effects of hypoxia on the alveolar epithelium. Proc Am Thorac Soc 2005;2:202-205.
32. Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002;82:569-600.
33. Hardiman KM, Matalon S. Modification of sodium transport and alveolar fluid clearance by hypoxia: mechanisms and physiological implications. Am J Respir Cell Mol Biol 2001;25:538-541.
34. Vivona ML, Matthay M, Chabaud MB, Friedlander G, Clerici C. Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: reversal by β-adrenergic agonist treatment. Am J Respir Cell Mol Biol 2001;25:554-561.
35. Thome UH, Davis IC, Nguyen SV, Shelton BJ, Matalon S. Modulation of sodium transport in fetal alveolar epithelial cells by oxygen and corticosterone. Am J Physiol Lung Cell Mol Physiol 2003;284:L376-L385.
36. Wodopia R, Ko HS, Billian J, Wiesner R, Bartsch P, Mairbaurl H. Hypoxia decreases proteins involved in epithelial electrolyte transport in A549 cells and rat lung. Am J Physiol Lung Cell Mol Physiol 2000;279:L1110-L1119.
37. Johnson MD, Bao HF, Helms MN, Chen XJ, Tigue Z, Jain L, Dobbs LG, Eaton DC. Functional ion channels in pulmonary alveolar type I cells support a role for type I cells in lung ion transport. Proc Natl Acad Sci USA 2006;103:4964-4969.
38. Johnson MD, Widdicombe JH, Allen L, Barbry P, Dobbs LG. Alveolar epithelial type I cells contain transport proteins and transport sodium, supporting an active role for type I cells in regulation of lung liquid homeostasis. Proc Natl Acad Sci USA 2002;99:1966-1971.
39. Mason RJ, Voelker DR. Regulatory mechanisms of surfactant secretion. Biochim Biophys Acta 1998;1408:226-240.
40. Wright JR, Dobbs LG. Regulation of pulmonary surfactant secretion and clearance. Annu Rev Physiol 1991;53:395-414.
41. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999;160:1843-1850.
42. Griese M, Maderlechner N, Ahrens P, Kitz R. Surfactant proteins A and D in children with pulmonary disease due to gastroesophageal reflux. Am J Respir Crit Care Med 2002;165:1546-1550.
43. 2 tolerance in rabbits with no increase in antioxidant enzymes. J Appl Physiol 1989;66:1679-1684.
44. Ware LB, Eisner MD, Thompson BT, Parsons PE, Matthay MA. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. AmJRespirCritCareMed2004; 170:766-772.
45. Flori HR, Ware LB, Milet M, Matthay MA. Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation. Pediatr Crit Care Med 2007;8:96-101.
46. Frank JA, Gutierrez JA, Jones KD, Allen L, Dobbs L, Matthay MA. Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am J Respir Crit Care Med 2002;165:242-249.
47. Muller AM, Skrzynski C, Skipka G, Muller KM. Expression of von Willebrand factor by human pulmonary endothelial cells in vivo. Respiration 2002;69:526-533.
48. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and FLI-1 in normal human tissues. J Histochem Cytochem 2006;54: 385-395.
49. Heads RJ, Yellon DM, Latchman DS. Differential cytoprotection against heat stress or hypoxia following expression of specific stress protein genes in myogenic cells. J Mol Cell Cardiol 1995;27:1669-1678.
50. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol Rev 2006;86:583-650.
51. Cardell LO, Lou YP, Takeyama K, Ueki IF, Lausier J, Nadel JA. Carbon monoxide, a cyclic GMP-related messenger, involved in hypoxic bronchodilation in vivo. Pulm Pharmacol Ther 1998;11:309-315.
52. Slebos DJ, Ryter SW, van der Toorn M, Liu F, Guo F, Baty CJ, Karlsson JM, Watkins SC, Kim HP, Wang X, et al. Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death. Am J Respir Cell Mol Biol 2007;36:409-417.